24% growth masks sequential margin collapse and execution risks
Sasken delivered strong YoY growth and order bookings, but sequential PAT fell 18.9% and Product Solutions margins halved. The real story lies in what management declined to guide on.
The quarter in context
+24% YoY
₹339.2 Cr; +1.6% QoQ
+135% YoY
₹23.5 Cr; -18.9% QoQ
5.9%
down 310 bps QoQ from 12.8%
$47M TCV
$34M new wins; 5 new logos
Sasken's headline reads like a growth story: ₹339 crore revenue, up 24% year-on-year, with strong order bookings of ₹47 million TCV in Q1. Profit jumped 135% YoY to ₹23.5 crore. But here's the tension: sequential PAT fell ₹2.9 crore (−18.9%), and Product Solutions gross margin halved from 12.8% to 5.9% in a single quarter. The YoY narrative masks a sharp deterioration in underlying execution.
Where the sequential decline came from
The PAT decline from Q4 to Q1 despite revenue growth reflects a structural shift, not a one-time event. Management attributed the margin collapse in Product Solutions to three factors: memory pricing (where Sasken acts as a pass-through but still absorbs carry margin), a shift in program mix toward lower-margin silicon productization, and component cost inflation. Software Services, by contrast, improved 240 bps to a 30.6% gross margin, lifting utilization to 85%. The two segments are moving in opposite directions — and the company has no timeline for Product Solutions recovery.
The product mix changed. Our silicon business is moving towards productization and that has an impact on the margins.
Management claims vs. what holds up
Revenue ₹339 Cr, up 24% YoY, 1.6% QoQ
SupportedRevenue ₹339.2 Cr, +24.0% YoY, +1.6% QoQ — exact match
Product Solutions margins stabilizing, expect improvement through year
ContradictedGross margin fell 310 bps QoQ to 5.9%, halved from Q4's 12.8%. Sequential revenue also fell 3.9%.
Disciplined profitable growth, margin improvement ahead
OverstatedYoY PAT +135% but QoQ −18.9%; product gross margin halved. CFO refused margin guidance.
60x4x3 strategy on track — 60 $4M+ customers in 3 years
ContradictedOnly 6 customers at $4M+ after 10 of 12 planned quarters (~75% of timeframe spent, ~10% of target achieved). MD said 3-year frame is 'metaphoric' and may take 1–2 more years.
Strong order backlog converts to stable near-term revenue
Partial$47M TCV Q1 bookings ($34M new wins) must convert to revenue in Q2–Q4. $40M ACV represents ~1.2 quarters of run-rate revenue; risk of lumpy conversion.
What changed on this call
60x4x3 timeline extended: MD said 3-year goal is 'metaphoric' and may take '1–2 more years'
Product Solutions margin structure reset: halved to 5.9%, attributed to silicon productization and memory/component costs
No FY27 margin guidance issued: CFO explicitly declined to provide EBITDA or PAT margin targets
Hyperscaler wins booked: agentic AI, LLM validation, and intelligent testing engagements from two different hyperscalers
Silicon Incubation Center opened in Hubballi; new Hyderabad center for engineering talent
Customer base grew from 79 to 93 active; 5 new logos in Q1
Operating cash flow remains negative for 2 years; CFO said 'work in progress' with large cash consumption expected in FY27
The bull-bear ledger
Bull: 24% YoY revenue growth; strong order bookings ($47M TCV, $34M new wins); customer base expanded 14 customers YoY to 93
Bull: Chip-to-Cognition strategy is differentiated; hyperscaler AI engagements are high-margin, long-duration wins
Bull: Software Services segment growing +24.3% YoY with improving margins (30.6%, +240 bps); utilization at 85%
Bear: Sequential PAT down ₹2.9 Cr (−18.9%) despite YoY growth; YoY narrative masks quarterly deterioration
Bear: Product Solutions gross margin halved QoQ to 5.9%; no recovery timeline provided by management
Bear: 60x4x3 strategy severely lagging: only 6 of 60 customers at $4M+ threshold after 10 quarters (75% time elapsed, 10% progress achieved)
Bear: Operating cash flow negative for 2 years; expected to remain negative through FY27 due to Borqs integration and working capital investments
Bear: Management refused FY27 margin guidance; signals uncertainty on recovery timeline and execution confidence
Risks, ranked by severity to a holder
Product Solutions margin structure deterioration
HighGross margin halved from 12.8% to 5.9% QoQ due to silicon productization, memory, and component costs. If persists, will drag consolidated OPM. No recovery target or timeline provided.
60x4x3 strategy severely lagging execution
HighOnly 6 of 60 target customers at $4M+ revenue run-rate after 10 quarters (75% planned time elapsed). MD reset expectation to '1–2 more years,' signaling 50%+ delay. Core growth strategy credibility damaged.
Operating cash flow negative for 2 years; expected to remain negative FY27
HighDespite ₹339 Cr revenue and ₹23.5 Cr PAT, cash flow remains negative due to Borqs integration, working capital, and inventory build. No clear path to cash-flow positive announced.
Borqs profitability break-even at $12M quarterly (~₹100 Cr annualized) not yet visible
MediumBorqs was promised to break even at $60–70M annualized; now reset to $12M quarterly. At current 5.9% Product Solutions margins, scaling Borqs profitably requires either significant revenue growth or substantial margin recovery. Both uncertain.
Management deflection on margin guidance and recovery timeline
MediumCFO explicitly refused to provide FY27 margin targets after analysts asked three times. Signals either internal uncertainty or unwillingness to commit. Reduces transparency.
Order bookings conversion risk
Medium$47M Q1 TCV bookings represent ~1.2 quarters of revenue. Must convert evenly in Q2–Q4 to avoid lumpy revenue. Silicon orders are multi-year; conversion timeline unclear.
How the street is positioned
Initial positive reaction, but stock remains under pressure. Sasken's result announcement (Jul 31, 2026) triggered a day-1 pop of +4.42%, which extended to +8.26% by day 3 and held at +6.76% by day 5. The market favored the YoY growth and order bookings, treating the sequential PAT decline and margin collapse as temporary noise. However, the stock at ₹1,971.4 sits 29% below its all-time high and below its SMA50 (₹2,058.28), suggesting investors remain cautious on the multi-quarter outlook. RSI of 59.9 (neutral) indicates no overbought condition.
Ownership and flows: FII ownership ticked up to 19.11% (gain of 0.57pp QoQ), and DII inched higher to 1.39% (gain of 0.34pp). The moves are modest, suggesting institutional investors are nibbling on weakness but not aggressively accumulating. Promoter holding remains stable at 42.95%. Bulk deal activity over the past 6 months shows mixed trading — no large insider-linked selling near recent highs, but no concentrated buying either. The lack of institutional conviction despite the pop is telling: the market bought the print but hasn't committed the capital to push the stock closer to its prior high.
Valuation context: At ₹1,971.4, the stock trades 29% below ATH and +98.93% above the 52-week low (₹991), suggesting it is no longer cheap. The 52-week range (₹991–₹2,780.2) shows the stock's volatility. The stock sits above SMA20 (₹1,886.35) but below SMA50, a mild bearish tilt. The market has priced in some recovery narrative (the pop) but not enough to erase the discount from recent highs — a clear signal that sequential deterioration and margin questions are a concern.
1 · Q2 Product Solutions margin stabilization
Did the 5.9% gross margin bottom in Q1, or will it compress further in Q2? Management promised 'full-year stabilization' but no target. Watch for sequential improvement; if margins compress further, the structural headwind is more severe than claimed.
2 · $47M TCV Q1 bookings conversion to revenue
Management must demonstrate even conversion of the $34M new wins across Q2–Q4. If conversion is lumpy (e.g., heavy in one quarter), it suggests customer bookings are volatile or multi-year deliveries are unpredictable. Also watch the ACV sustainability ($40M for 12 months is critical).
3 · Operating cash flow inflection
Negative for 2 years and expected to worsen in FY27. Management must articulate a path to cash-flow positive; without it, the company's ability to fund growth, shareholder returns, or debt repayment is constrained. Watch for any update on cash burn rate or timeline to positive OCF.
The verdict
Sasken delivered on headline growth (24% YoY, ₹339 Cr revenue) and order bookings ($47M TCV). But the quarter reveals two deeper issues: sequential deterioration masked by year-on-year comparisons, and structural margin pressure in the core Product Solutions business. The 60x4x3 strategy, once a key pillar, is now only 10% achieved after 75% of planned time; management reset the timeline to '1–2 more years,' effectively doubling the goal. Operating cash flow remains negative after 2 years, with no clear recovery plan. Management's refusal to guide on FY27 margins suggests internal uncertainty, not conservative positioning.
The market's day-1 pop (+4.42%) reflects enthusiasm for growth and hyperscaler wins, but the stock's position 29% below ATH and below SMA50, combined with modest institutional accumulation (FII +0.57pp), signals caution. Investors bought the print but didn't commit capital to push it back to recent highs.
Rating: HOLD. The company is not in distress — growth is real, the strategy is sound, and hyperscaler engagements are valuable. But execution risk is material: Product Solutions margins are broken (5.9%), 60x4x3 is lagging severely, and cash flow is underwater. The quarter is a steady deceleration, not a step-change, but one that should concern holders. The number to track from here is sequential product margin recovery in Q2; if it stabilizes or improves, the bear case weakens. If it compresses further, the structural nature of the headwind is confirmed, and repricing risk rises. Until then, patience over conviction.
Published 2026-08-17 | Region: IN | Quarters tracked: Q1 FY-2027 | Confidence: 6/10
Sasken Q1 FY27: consolidated PAT jumps 135% YoY to ₹23.5 Cr on margin expansion; revenue up 24%
PAT +135.1% YoY · revenue +24% · margins expanding
₹339.24 Cr
+24% YoY
₹23.52 Cr
+135.1% YoY
6.74%
+3.2pp YoY
₹16.37
Sasken's consolidated Q1 FY27 print is a clear YoY beat on every headline line: revenue of ₹339.24 Cr grew 24.0% year-on-year, PAT of ₹23.52 Cr grew 135.1% YoY, and PAT margin expanded to 6.9% from 3.6% a year ago (EBITDA margin 9.5% vs 5.4%). No consensus PAT/revenue estimate could be located for this specific quarter despite searching — Sasken is a small/mid-cap with thin formal sell-side coverage and no previews were found — so vsStreet is recorded as unknown rather than assumed. The company also gives no formal forward numeric guidance; management's language has been directional ("sustaining Services momentum," "disciplined execution") rather than a specific target, so there is no guidance to grade against either.
Q1 FY-2027 vs prior quarters
Sequentially the picture is softer and management flags this plainly in its own release: PAT fell 18.9% QoQ and EBITDA margin compressed from 9.9% to 9.5%. Two things explain the gap rather than any operating deterioration in the core business. First, other income fell 36.9% QoQ (₹15.33 Cr to ₹9.67 Cr) and finance costs nearly doubled (₹0.75 Cr to ₹1.44 Cr), both below-the-line items unrelated to operations. Second, Product Solutions gross margin compressed sharply to 5.9% from 12.8% in Q4 FY26 as the segment absorbed continuing memory supply and pricing pressure even as segment revenue held up (down only 3.9% QoQ, still up 23.6% YoY) — the company says higher shipment volumes and contractual cost pass-through cushioned the topline. Software Services, in contrast, expanded gross margin to 30.6% from 23.4% a year ago on utilisation gains (up to 85.1% from 79.2% YoY) and cost discipline, and remains the larger and faster-improving segment at ₹219.6 Cr of revenue (64.7% of the mix) versus Product Solutions' ₹119.7 Cr.
The stock went into the print at ₹1,821.8, down 15.6% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters; revenue is at a 6-quarter high.
What the summary numbers don't show
Cash-positive, debt-free balance sheet — total assets ₹1,261.8 Cr vs ₹1,166.1 Cr at March-26; trade receivables rose to ₹232.4 Cr from ₹174.7 Cr
CFO Priyaranjan framed the quarter as reflecting "operating leverage now coming through as we scale," and CEO Rajiv Mody pointed to deeper customer partnerships and the Chip-to-Cognition positioning — both claims are consistent with the numbers: order bookings of $47.1M ($33.7M new, five new logos) and an active client base that grew to 93 from 79 a year ago support the scaling narrative, though only 6 of those accounts are currently in the $4M+ LTM band the company's 60×4×3 strategy targets. Standalone PAT of ₹28.86 Cr on ₹155.48 Cr revenue (EPS ₹19.00) is the India entity alone and runs ahead of the consolidated print because it excludes the Borqs/Product Solutions drag. Concurrent with the results, the board also convened the 38th AGM and disclosed director Sunirmal Talukdar's exit (July 21, 2026) — a governance item with no direct read-through to this quarter's numbers.
W1
Product Solutions gross margin recovery — fell to 5.9% in Q1 FY27 from 12.8% in Q4 FY26 on memory pricing pressure; watch if alternate-supplier qualification and cost pass-throughs (flagged by management) lift it back in Q2
W2
Sequential PAT/EBITDA trajectory — Q1 PAT (₹23.52 Cr) and EBITDA margin (9.5%) both declined QoQ from Q4's ₹29.00 Cr/9.9%; confirm whether Q2 resumes the QoQ growth pattern built through FY26
W3
60×4×3 strategy conversion — active client base at 93 with only 6 accounts currently in the $4M+ LTM band against a target of 60 marquee $4M+ accounts in 3 years; watch conversion pace next quarter
Audited, clean typeset tables, columns unambiguous. No exceptional item in any quarterly column (₹830.80L consol/₹457.30L standalone labour-code impact sits only in the FY26 annual column, not in Q1FY27, Q4FY26 or Q1FY26 quarters), so YoY/QoQ growth needs no adjustment. Consolidated PAT of ₹23.52 Cr includes a negative ₹1.34 Cr non-controlling interest (Borqs step-down subsidiary), so owners'-share PAT is actually ₹24.86 Cr.
24% growth masks sequential margin collapse in Product Solutions
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Revenue and EBITDA numbers match reported results exactly. However, sequential deterioration and margin collapse in Product Solutions not adequately explained; management deflected on timeline and margins.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Sasken delivered 24% YoY revenue growth with strong order bookings ($47M TCV), and the Chip-to-Cognition strategy is strategically sound. However, sequential PAT declined 18.9% despite YoY growth (masked by normalizing one-offs), and Product Solutions gross margins halved from 12.8% to 5.9%—a structural headwind, not temporary. The 60x4x3 strategy has achieved only 10% of its customer target after 75% of planned time. Without margin guidance and with negative free cash flow for two years, execution risk is material.
₹339.2 Cr
Revenue · +24% YoY₹23.5 Cr
Reported PAT · +135.1% YoYCompressing
Margins · vs guidance: UnverifiedDid the claims hold up?
Revenue ₹339 Cr, up 24% YoY, 1.6% QoQ
METRevenue ₹339.2 Cr, +24.0% YoY, +1.6% QoQ — exact match
EBITDA margin 9.5%, PAT margin 6.9%
METOPM 9.5%, NPM 6.7% — delivered; PAT ₹23 Cr vs ₹23.5 Cr reported, close match
Product Solutions margins stabilizing, expect improvement through year
MISSGross margin fell 310 bps QoQ to 5.9%, halved from Q4's 12.8%. Sequential PAT down 18.9% despite revenue up
Disciplined profitable growth, margin improvement ahead
OVERSTATEDYoY PAT +135% but QoQ -18.9%; product gross margin halved. CFO refused margin guidance
60x4x3 strategy on track — 60 $4M+ customers, $4M each, 3 years
MISSOnly 6 customers at $4M+; 10 quarters into strategy = ~75% of timeframe spent but only ~10% of customer target achieved
Earnings quality
What changed since the last call
Product Solutions margin collapsed
DowngradeGross margin fell from 12.8% (Q4 FY26) to 5.9% (Q1 FY27), a 310 bps drop. Sequential revenue also fell 3.9% despite 23.6% YoY growth.
Sequential PAT down despite YoY growth
DowngradePAT fell ₹2.9 Cr QoQ (-18.9%) to ₹23.5 Cr, masked by FX tailwind in Q4. YoY +135% obscures quarterly deceleration.
No formal margin guidance issued
NeutralCFO explicitly stated management will not give FY27 margin guidance, citing ongoing optimization. No prior guidance to compare, so guidanceChange=none.
60x4x3 strategy timeline reset
DowngradeMD said 3-year target is 'metaphoric' and may take '1-2 more years.' After 10 quarters, only 6/60 customers reached $4M+ (10% progress, 75% time elapsed).
The Q&A
Analysts pressed hard on three fronts: (1) Why only 6/60 customers at $4M+ after 10 quarters? Mody deflected, saying timeframe is metaphoric. (2) Why did Product Solutions margin halve? CFO blamed memory/mix, hedged on recovery. (3) Why is cash flow negative 2 years running despite profit growth? CFO said 'work in progress,' no timeline. Management held positions but avoided specifics.
60x4x3 customer strategy — Keshav Sureka, Niveshaay
PartialMody: 3-year was metaphoric, may take 1-2 more years. Focus is on ensuring remaining 87 of 93 customers sustain and grow to $4M+. Adding 5-6 sales heads during year.
Product Solutions margin — Keshav Sureka, Niveshaay
PartialPriyaranjan: Memory pricing affects carry margin even if passed through. Product mix changed; silicon moving to productization, lower-margin initially. Expect stabilization full-year.
Hyperscaler engagements — Keshav Sureka, Niveshaay
AnsweredMody: Different hyperscalers.
Revenue by segment/vertical — Priyank Chheda, Vallum Capital
DodgedPriyaranjan: We disclose only Product Solutions and Software Services. Segment breakdown would distort picture at this scale. Both growing >20% YoY across verticals.
Order book tenure — Priyank Chheda, Vallum Capital
AnsweredPriyaranjan: $47M is quarterly bookings, not total backlog. $40.5M is ACV (12-month revenue). Order backlog gives 9-10 months carry like IT services. Silicon orders are multi-year; mix varies.
Sales and seniority — Nikhil Chaudhary, Toro Wealth Managers
PartialMody: Adding 5-6 sales heads year; leadership also sells. Priyaranjan: Mix of lateral/freshers. Anup: Teams trained for independence, multiple levels deep, niche skills grown in-house.
60x4x3 growth target — Naveen Baid, Nuvama AMC
PartialMody: 3 was metaphoric. Growth is the imperative; all three segments (silicon, devices, services) have potential. AI and Make-in-India are tailwinds. We crossed $50M to $125M in 2 years; we can do it.
Borqs rationale — Manik Taneja, Bowhead Investments
AnsweredMody: Borqs integration works well; scaled both services and product. ODM enables full-product ownership. Priyaranjan: Q1 FY26 headcount was 2,200 (300 from Borqs). Q1 FY27 is 2,658, all organic. AI is built into all work.
Cash flow headwind — Samarth Singh, TPF Capital
PartialPriyaranjan: Investing in business (Borqs, capacity, WC). No collections issues. Will be large consumption this year too. Using mix of internal accruals and external funds. Work in progress.
Borqs break-even — Samarth Singh, TPF Capital
AnsweredPriyaranjan: Break-even is ~$12M quarterly revenue. From there on, adds to bottom line as scale increases.
Margin guidance — Dev Gulwani, CARE PMS
DodgedPriyaranjan: We do not want to give any guidance on margins at this point. Constantly driving efficiencies and value pricing. Goal is to improve margins.
Foundry partnerships — Samarth Singh, TPF Capital
PartialAnup: All three in progress, substantial progress made, resulted in additional design work. Cannot announce due to confidentiality.
RF and mmWave projects — Sanjay Elangovan, ithought PMS
PartialAnup: Analog/RF/mmWave transitioning from niche to pervasive (chiplets, memory, package design). Revenue mix already reflects implementation. Cannot be specific. More as AI-enabled design grows.
Two-wheeler instrument cluster — Sanjay Elangovan, ithought PMS
DodgedHareesh: Was reference design for Qualcomm; module suppliers took it but market still imports from China. China Plus One creating demand but cost-sensitive. Exploring NAD and other modules instead.
Guidance
No FY27 revenue guidance issued
N/AManagement stated focus on 'disciplined and profitable growth' but declined to quantify FY27 targets. Emphasized converting $47M TCV Q1 bookings to revenue.
No FY27 margin guidance issued
N/ACFO explicitly stated: 'we do not want to give any guidance on the margins at this point in time.' Said margins will improve through efficiency and value pricing but no targets.
No capex guidance; mentioned investment in capacity and WC
LowPriyaranjan said management expects 'large consumption of cash' in FY27 for growth investments. Will finance via internal accruals and external funds.
Risks the call surfaced
Product Solutions margin
HighGross margin halved from 12.8% (Q4) to 5.9% (Q1). CFO attributed to memory pricing pass-through, component costs, program mix, silicon productization. No recovery timeline. If persists, will drag consolidated margins.
Borqs profitability
MediumBorqs broke even at prior guidance of $60-70M annualized; now scaled to break-even at ~$12M quarterly ($48M). At current low gross margins (5.9%), scaling requires either substantial revenue growth or margin recovery. Integration is ongoing.
60x4x3 strategy execution
MediumStrategy target is 60 customers each at $4M+ revenue run-rate, achieved in 3 years. After 10 of 12 planned quarters, only 6 customers achieved. MD said 3-year timeframe is 'metaphoric' and may take '1-2 more years,' resetting expectations. This is a 10% achievement on 75% time spent.
Operating cash flow
MediumDespite 24% revenue growth and strong PAT growth YoY, OCF negative for 2 years due to working capital and FA investments (Borqs integration, capacity, inventory build for memory shortage). Management said 'work in progress' on returning to positive cash, with large cash consumption expected in FY27.
Customer concentration
LowDespite adding 14 new customers YoY (79 → 93), top 5 concentration rose from ~52% to 56%. Indicates large wins are concentrating in fewer customers, typical for growth but increases churn risk for a large account.
Silicon business early stage
MediumSilicon business is in early stage, currently unprofitable. Management stated break-even is at ~$12M quarterly revenue ($48M annualized). Productization is moving to lower margins initially. Investments in foundry partnerships (GlobalFoundries, Intel, TSMC) ongoing but no announced wins yet.
Management
Score 6/10. Transparent on numbers (revenue, EBITDA match delivered results exactly). Deflected on margin outlook (CFO refused FY27 guidance). Vague on product mix drivers and customer pipeline. Strategic narrative (Chip-to-Cognition) clear but execution details withheld. Delivered 24% YoY revenue growth and achieved order bookings ($47M TCV). But sequential PAT down 19%, Product Solutions margins halved, and 60x4x3 strategy only 10% achieved after 75% of time. Borqs integration progressing but financial results show margin stress, not synergy capture yet.
1 · Q2-Q4 FY27
Convert $47M TCV bookings to revenue; normalize Product Solutions margins
2 · H2 FY27
Borqs break-even at $12M quarterly revenue; scale silicon productization
3 · FY28
Test 60x4x3 progress: customers reaching $4M+ threshold (currently 6/60)
Without margin guidance and with negative free cash flow for two years, execution risk is material.